Firms

RYSE Asset Management

RYSE Asset Management

ryseam.com

London-based venture capital firm investing at seed and Series A in digital diagnostics, digital therapeutics, medical devices, data and discovery platforms, and health AI. It helps founders commercialize and distribute health technologies through collaborations with health systems, pharmaceutical and medical-device companies. Its clinical focus includes mental health, cardiovascular and metabolic conditions, oncology and women’s health; its Special Opportunities Fund invested in Braingaze’s digital detection and treatment of neurocognitive conditions.

Founded
2017
Type
Venture capital

Funds1

  • RYSE Special Opportunities Fund—

    Early-stage global health-technology venture fund investing from seed to Series A in digital diagnostics, digital therapeutics and medical devices, including neurocognitive health. First close announced March 5, 2024; the manager describes the fund as US$50m but does not separately disclose first-close proceeds.

Team

Operations and support

Aleksandar PetrovićVenture Advisor
Annalisa JenkinsAnnalisa JenkinsChair
Benjamin MaddisonVenture Advisor
David HolbrookVenture Advisor
David SeemungalPartner, Partnerships and Distribution
Everett KaminBoard Advisor
Fergus HayBoard Advisor
John Lee AllenPartner, Healthcare
Kevin RobertsLeadership
Laila Samady-MustadVenture Partner
Shabir ChowdharyFounding Partner, Finance and Structuring
Vivien de Tusch-LecGeneral Partner, Strategy and Growth

Co-investing

Artesian
Orbit Startups
William Bao Bean

Investments